T1	Association 0 11	Association
E1	Association:T1 snp_int:T5 bc:T2
T2	Cancer 85 98	Breast Cancer
T3	Entity 107 129	Chinese Han Population
T4	Spec 164 169	Study
R1	Speculation_marker Arg1:E1 Arg2:T4	
T5	SNP 20 51	Single Nucleotide Polymorphisms
T6	Entity 55 75	DNA Polymerase Kappa
R2	SNP_coupled_gene Arg1:T5 Arg2:T6	
R3	Population_assignment Arg1:T5 Arg2:T3	
T7	Patho_physiology 475 500	translesion DNA synthesis
E2	Patho_physiology:T7 Agent:T5
T9	Entity 665 669	POLK
R4	Equiv Arg1:T9 Arg2:T6	
T8	SNP 670 686	genetic variants
R5	SNP_coupled_gene Arg1:T8 Arg2:T9	
T10	Association 657 661	role
E3	Association:T10 snp_int:T8 bc:T11
T11	Cancer 690 703	breast cancer
T12	Cancer 705 707	BC
R6	Equiv Arg1:T12 Arg2:T11	
T13	Spec 717 730	to be defined
R7	Speculation_marker Arg1:E3 Arg2:T13	
T14	Spec 759 767	evaluate
T15	Association 772 779	effects
E4	Association:T15 bc:T16 snp_int:T18
T16	Cancer 805 807	BC
T17	Entity 783 787	POLK
T18	SNP 788 801	polymorphisms
R8	SNP_coupled_gene Arg1:T18 Arg2:T17	
R9	Speculation_marker Arg1:E4 Arg2:T14	
T19	SNP 913 922	rs3213801
T20	SNP 924 934	rs10077427
T21	SNP 940 949	rs5744533
T22	Entity 907 911	POLK
R10	SNP_coupled_gene Arg1:T19 Arg2:T22	
R11	SNP_coupled_gene Arg1:T20 Arg2:T22	
R12	SNP_coupled_gene Arg1:T21 Arg2:T22	
R13	Member Arg1:T18 Arg2:T19	
R14	Member Arg1:T18 Arg2:T20	
R15	Member Arg1:T18 Arg2:T21	
R16	Population_assignment Arg1:T18 Arg2:T3	
T23	Association 1029 1040	association
E5	Association:T23 bc:T25
T24	Spec 1065 1073	assessed
T25	Cancer 1058 1060	BC
R17	Speculation_marker Arg1:E5 Arg2:T24	
R18	Equiv Arg1:E5 Arg2:E4	
T26	Level 1191 1216	statistically significant
T27	Entity 1270 1274	POLK
T28	SNP 1275 1285	rs10077427
R19	SNP_coupled_gene Arg1:T28 Arg2:T27	
T29	Association 1217 1227	difference
E6	Association:T29 bc:T25 snp_int:T28
R20	Level_marker Arg1:E6 Arg2:T26	
A1	Level E6 High
T30	Neg 1304 1313	excluding
T31	Entity 1318 1327	recessive
T32	SNP 1275 1285	rs10077427
R21	SNP_coupled_gene Arg1:T32 Arg2:T27	
T33	Association 1217 1227	difference
E7	Association:T33 snp_int:T32 bc:T25
R22	Negation_marker Arg1:E7 Arg2:T30	
R23	Genotype Arg1:T32 Arg2:T31	
T34	SNP 1448 1458	rs10077427
T35	Association 1337 1357	positive correlation
E8	Association:T35 snp_int:T34 bc:T36
T36	Cancer 1381 1411;1417 1442	positive progesterone receptor status, higher Ki67 index
A2	Cancer_Type T36 Horm+HER2-Ki67+
R24	Population_assignment Arg1:T32 Arg2:T3	
R25	Population_assignment Arg1:T28 Arg2:T3	
R26	Population_assignment Arg1:T34 Arg2:T3	
T37	SNP 1477 1486	rs5744533
T38	Level 1562 1582	significantly higher
T39	Cancer 1586 1588	BC
T40	Association 1545 1556	frequencies
E9	Association:T40 snp_int:T37 bc:T39
A3	Level E9 High
R27	Level_marker Arg1:E9 Arg2:T38	
T41	Entity 1505 1515;1538 1544	codominant models
T42	Entity 1517 1525;1538 1544	dominant models
T43	Entity 1531 1544	allele models
R28	Genotype Arg1:T37 Arg2:T41	
R29	Genotype Arg1:T37 Arg2:T42	
R30	SNP_allele Arg1:T37 Arg2:T43	
R31	Population_assignment Arg1:T37 Arg2:T44	
T44	Entity 1983 1996	Chinese women
R32	Equiv Arg1:T44 Arg2:T3	
T45	SNP 1668 1677	rs5744533
T46	Protective_effect 1688 1703	protective role
E10	Protective_effect:T46 Agent:T45 Theme:T39
T47	Entity 1711 1725	postmenopausal
R33	Risk_Factor Arg1:T45 Arg2:T47	
T48	Neg 1760 1763	any
R34	Population_assignment Arg1:T45 Arg2:T44	
T49	Association 1764 1776	associations
E11	Association:T49 snp_int:T50 bc:T51
R35	Negation_marker Arg1:E11 Arg2:T48	
T50	SNP 1785 1794	rs3213801
R36	Population_assignment Arg1:T50 Arg2:T44	
T51	Cancer 1830 1832	BC
T52	Entity 1859 1863	POLK
T53	SNP 1864 1877	polymorphisms
R37	SNP_coupled_gene Arg1:T53 Arg2:T52	
R38	SNP_coupled_gene Arg1:T50 Arg2:T52	
T54	Spec 1878 1881	may
T55	Association 1882 1891	influence
E12	Association:T55 bc:T56 snp_int:T53
T56	Cancer 1915 1917	BC
R39	Speculation_marker Arg1:E12 Arg2:T54	
R40	Population_assignment Arg1:T53 Arg2:T44	
